Patent Yard Sign in
Expired Canadian patentCanada

3-(4'-aminobutylamino)propylaminobleomycin derivatives, and processes of the preparation thereof

CA 1270600 C · Owner: Muraoka, Yasuhiko · Inventors: Umezawa, Hamao; Muraoka, Yasuhiko; Fujii, Akio

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed is a 3-(4'-aminobutylamino) propylaminobleomycin having low pulmonary toxicity, which expressed by the following general formula, BX-NH-(CH2)3-A-(CH2)4-B, wherein BX represents a residue remaining after removing a hydroxyl group from the carboxyl group of bleomycinic acid A represents a group of the, formula, or in which R1 represents (i) a hydrogen atom (ii) an alkyl group having, 1 to 10 carbon atoms or (iii) a methyl group or a methyl group substituted by at least one of a phenyl group and a cycloalkyl group having 5 to 13 carbon atoms,which substituents may be unsubstituted or further substituted in more than one position by one or more substituents selected from the group …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted June 19, 1990. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 19, 2007.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 26, 1984
GrantedJune 19, 1990
Term endedJune 19, 2007
Patent numberCA 1270600 C
Classification (IPC)C07K9/00 +2 more

Timeline

Timeline From CIPO dates

19851988199119941997200020032006Application filedJune 26, 1984Patent grantedJune 19, 1990Term endedJune 19, 2007

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.